Progress and challenges in implementing the research on ESKAPE pathogens. - Wikidata - awgldk - TriplyDB

Progress and challenges in implementing the research on ESKAPE pathogens.

Progress and challenges in implementing the research on ESKAPE pathogens.

http://www.wikidata.org/entity/Q45710828

about

Focal Targeting of the Bacterial Envelope by Antimicrobial Peptides Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens Next-generation antimicrobials: from chemical biology to first-in-class drugs Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care Genome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates.Rapid identification of ESKAPE bacterial strains using an autonomous microfluidic device.Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.Inhibition of cell division induced by external guide sequences (EGS Technology) targeting ftsZ Ceftolozane/Tazobactam: a new option in the treatment of complicated gram-negative infections.Occurrence, distribution, dereplication and efficient discovery of thiazolyl peptides by sensitive-resistant pair screening.Novel classes of antibiotics or more of the same?The identification and functional characterization of WxL proteins from Enterococcus faecium reveal surface proteins involved in extracellular matrix interactions Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.General and condition-specific essential functions of Pseudomonas aeruginosa.Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Microspectrometric insights on the uptake of antibiotics at the single bacterial cell level Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile Whole genome sequence of Klebsiella pneumoniae U25, a hypermucoviscous, multidrug resistant, biofilm producing isolate from India.Bacterial Transcription as a Target for Antibacterial Drug Development.A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection.Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics.Multilocus Sequence Typing Analysis of Carbapenem-Resistant Acinetobacter baumannii in a Chinese Burns Institute.Label-Free Detection and Discrimination of Bacterial Pathogens Based on Hemin Recognition.Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens.New antibacterial agents: patent applications published in 2010.New antibacterial agents: patent applications published in 2011.Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.Evaluation of Parameters for High Efficiency Transformation of Acinetobacter baumannii.Multidrug-resistant bacteria in hematology patients: emerging threats.Efficacy, pharmacokinetic and pharmacodynamic profile of ceftolozane + tazobactam in the treatment of complicated urinary tract infections.Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.Recent Developments in Antimicrobial Polymers: A Review.Synthesis, Physico-chemical Characterization, Crystal Structure and Influence on Microbial and Tumor Cells of Some Co(II) Complexes with 5,7-Dimethyl-1,2,4-triazolo[1,5-a]pyrimidine.

P2860

Q26744785-CEB55779-B249-49EE-87C0-B6D64ED8FBA9 Q26747594-FD1AC9D7-6137-4FA6-8AE3-26C4E4B4C3E0 Q26799749-2968EA8C-428E-4EAA-92E7-9835D6A39863 Q28546591-869DB724-3EA3-41A6-8651-460222C13A7E Q28550029-9CAC63E0-1E64-4916-B9C3-F1024F2E5033 Q28550788-B5FC2EEB-D0C2-40CE-899F-81801E3440D1 Q30397647-F1B3DE64-E3D1-4CFE-A956-450884F7DDA5 Q33779989-61B6130D-FD27-4433-BCA3-97484E4609E2 Q34358257-645D4699-4AB6-4D11-9C30-D587B6E9D9D9 Q34393008-4AF41838-4C08-44E7-8E37-077F00369195 Q34460507-BCC1DD6E-4CCA-4656-BB9B-F1B64731F97F Q34688710-A1DC0A3F-FA1A-407F-BA0B-DEC6C52AB63E Q34784122-43668528-65E1-451C-88CB-E33D5B266849 Q34903245-D0754D71-2F02-4D7D-B7F8-AC26B7A870DD Q35074891-63B37097-EFDD-4F89-939D-1F31E32760B9 Q35104348-1CB9CBF4-BF31-4302-AD69-C4C007336EE8 Q35549350-36EC8041-CF72-4213-AD56-6DF664E4A716 Q35617499-3B5E4F3A-B488-45BF-A54A-F37DD5B5543D Q35781198-6A7AA249-59D7-4078-B005-0D10CEB375D0 Q35975439-67164452-2894-423A-A5D8-A0D75DCD99F5 Q36363784-A8942F28-8ADD-4C26-BF56-BBF82445C026 Q36479306-775C1304-8481-4C0B-AE40-281B719140BE Q36571083-8F14658E-4234-4D26-A0F8-ADED3C82DD4A Q36631410-9277FEC5-91E2-4939-B9C2-0B74CCDD57BC Q36712172-1C7EDE03-552C-4738-A1D8-64E2E3CD4F76 Q37182594-2C77C604-E099-49F7-A006-038E1B68E5D7 Q37402130-0BBDB48F-457D-4E5F-B387-6A8B12EE0231 Q37643778-7717D855-6AEF-47F4-9F96-33268416706E Q37680591-FBDD8B58-615C-4CD9-8D54-8BA597CB3D0A Q38076452-42698FBE-8C7A-4C3B-8857-D10BB07F92BC Q38162949-BD1CF194-2611-44FD-9381-6282AD044F70 Q38172657-0987CDFF-5F20-431F-A15C-6DE12A87B3C4 Q38541624-EE69C349-6E02-44D5-8F68-B91A91B01F0D Q38622903-8B478122-46AF-4EBA-B851-F0BDB6FA7A60 Q38838498-67CF413E-8C94-4AE9-963A-D52981BD41DF Q38872130-E1080113-A32C-4185-A0A2-8FECE8C35465 Q38986360-4AC9410D-821C-436A-AB3C-46AE68A511BA Q39265442-9A8B22CF-75A9-40A4-B605-7DD091B55E5C Q40107966-34C2423A-361F-4165-8A4F-B6F399A692A1 Q40110889-40F805C6-F69B-414E-996B-E00B852656DD

P2860

Progress and challenges in implementing the research on ESKAPE pathogens.

http://www.wikidata.org/entity/Q45710828

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Progress and challenges in implementing the research on ESKAPE pathogens.

@en

Progress and challenges in implementing the research on ESKAPE pathogens.

@nl

type

label

Progress and challenges in implementing the research on ESKAPE pathogens.

@en

Progress and challenges in implementing the research on ESKAPE pathogens.

@nl

prefLabel

Progress and challenges in implementing the research on ESKAPE pathogens.

@en

Progress and challenges in implementing the research on ESKAPE pathogens.

@nl

P1433

Q45710828-BFD3B1B9-5EC1-4C26-A7C7-5F5FFB6F0B74

P1476

Q45710828-4252E8A7-87EF-43EE-8057-065B553BA88C

P2093

Q45710828-6D5FA848-7F3B-4613-BA9D-861CB58BFD0F

P2860

Q45710828-0494235C-414C-4090-84CD-C42E839EC1F4

Q45710828-0992E85B-C756-4289-8FE8-6886E464DBBA

Q45710828-196B7870-94BD-48F0-9427-EFEB6DE0DB04

Q45710828-1AA5AD69-356D-4BA6-B5CC-9CDDEF6D6B41

Q45710828-213616AD-93CE-4CA0-AA34-97B2C75CF640

Q45710828-21A75882-2E13-43E6-9316-00E64CF61456

Q45710828-2AABCF9C-C68C-4C5D-983D-7BDB0982A150

Q45710828-3042AF2B-D308-4AAD-B85A-97F22ABD8E03

Q45710828-34625412-C6C1-4AD1-8838-86FB6F91B558

Q45710828-3615E334-5020-4E45-B86F-4A121DAD3A71

P304

Q45710828-C31A4359-8B0A-4E45-BB77-91506314D957

P31

Q45710828-32933091-0608-4F7B-9CD3-8611E2EFC021

P356

Q45710828-4AF36159-E006-4501-8CFE-51CB8FBB5539

P478

Q45710828-89C14369-9891-449F-B4FA-796DEA55DF1B

P577

Q45710828-47E0A80F-0AA1-48D0-91A5-D6F9A079C0D5

P5875

Q45710828-ADD1C31C-013E-48DC-9D3C-3D433D077EAB

P698

Q45710828-B3DEE965-A274-4CED-91CE-E76420E7EBA0

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Progress and challenges in implementing the research on ESKAPE pathogens.

@en

P2093

Louis B Rice

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmid-mediated quinolone resistance: a multifaceted threat

The role of beta-lactamase-producing-bacteria in mixed infections

Comparative genomics of multidrug resistance in Acinetobacter baumannii

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Molecular basis of bacterial outer membrane permeability

AmpD, essential for both beta-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase.

An intervention to decrease catheter-related bloodstream infections in the ICU.

Acinetobacter baumannii: emergence of a successful pathogen

P304

S7-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/655995

http://www.w3.org/2001/XMLSchema#string

P478

31 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47369532

http://www.w3.org/2001/XMLSchema#string

P698

20929376

http://www.w3.org/2001/XMLSchema#string